Barricarte A

No ORCID on file · 2 papers in corpus · active 2016-2019
2019
Development and validation of circulating CA125 prediction models in postmenopausal women.
Journal of ovarian research ·doi:10.1186/s13048-019-0591-4

BackgroundCancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal charac…

2016
Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort.
International journal of cancer ·doi:10.1002/ijc.29853

Acrylamide, classified in 1994 by IARC as "probably carcinogenic to humans," was discovered in 2002 in some heat-treated, carbohydrate-rich foods. Four prospective studies have evaluated the association between dietary acrylamide intake and…